title: Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis.
abstract: OBJECTIVE
  Immunohistochemical prognostic factors of pulmonary metastatic colorectal cancer lesions have not been well investigated. The study was conducted to identify the immunohistochemical prognostic factors of metastasized colorectal cancer.
  
  
  METHODS
  We immunohistochemically investigated the expression of insulin-like growth factor-1 receptor (IGF1-R), E-cadherin, beta-catenin, and p53 using a tissue microarray in the surgical specimens of 86 metastatic lesions.
  
  
  RESULTS
  The univariate analysis revealed E-cadherin and membrane beta-catenin positive to be prognostic factors. IGF1-R and p53 were not significantly associated with the patient's survival. In multivariate analysis, the reduced expression of E-cadherin, aerogenous spread with floating cancer cell clusters and vascular invasion were independent prognostic factors.
  
  
  CONCLUSIONS
  The reduced expression of E-cadherin in the pulmonary metastatic lesions was an independent predictor of poor survival after pulmonary metastasectomy.
authors.affiliation: Pathology Division, National Cancer Center Research Institute East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Shiono
authors.forename: G
authors.initials: G
authors.lastname: Ishii
authors.forename: K
authors.initials: K
authors.lastname: Nagai
authors.forename: Y
authors.initials: Y
authors.lastname: Murata
authors.forename: K
authors.initials: K
authors.lastname: Tsuta
authors.forename: J
authors.initials: J
authors.lastname: Nitadori
authors.forename: T
authors.initials: T
authors.lastname: Kodama
authors.forename: A
authors.initials: A
authors.lastname: Ochiai
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D015820:Cadherins / Q000378:metabolism; D002277:Carcinoma / Q000378:metabolism* / Q000556:secondary / Q000601:surgery; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000378:metabolism* / Q000556:secondary / Q000601:surgery; D011013:Pneumonectomy; D011379:Prognosis; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D012189:Retrospective Studies; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D015820:Cadherins; D016159:Tumor Suppressor Protein p53; D051176:beta Catenin; D017526:Receptor, IGF Type 1